Patents by Inventor J. Milton Harris

J. Milton Harris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7943141
    Abstract: The present disclosure provides terminally activated monofunctional POZ derivatives having a range of functional active groups allowing conjugation of the monofunctional POZ derivatives to a variety of target molecules under a wide range of reaction conditions to produce a hydrolytically stable target molecule-POZ conjugate. Furthermore, the present disclosure provides novel methods of synthesis for the disclosed terminally activated monofunctional POZ derivatives and hydrolytically stable target molecule-POZ conjugates created using the disclosed terminally activated monofunctional POZ derivatives.
    Type: Grant
    Filed: February 28, 2008
    Date of Patent: May 17, 2011
    Assignee: Serina Therapeutics, Inc.
    Inventors: J. Milton Harris, Michael David Bentley, Kunsang Yoon, Zhihao Fang, Francesco Maria Veronese
  • Patent number: 7910685
    Abstract: Conjugates between a protein and a water soluble polymer comprising multiple degradable carbonate linkages are provided.
    Type: Grant
    Filed: June 29, 2010
    Date of Patent: March 22, 2011
    Assignee: Nektar Therapeutics
    Inventors: J. Milton Harris, Michael D. Bentley, Xuan Zhao, Xiaoming Shen
  • Patent number: 7887789
    Abstract: Polymeric reagents are provided comprising a moiety of atoms arranged in a specific order, wherein the moiety is positioned between a water-soluble polymer and a reactive group. The polymeric reagents are useful for, among other things, forming polymer-active agent conjugates. Related methods, compositions, preparations, and so forth are also provided.
    Type: Grant
    Filed: May 21, 2004
    Date of Patent: February 15, 2011
    Assignee: Nektar Therapeutics
    Inventors: J. Milton Harris, Antoni Kozlowski, Samuel P. McManus, Michael D. Bentley, Stephen A. Charles
  • Publication number: 20110009589
    Abstract: A heterobifunctional poly(ethylene glycol) is provided having a hydrolytically degradable linkage, a first terminus comprising an acrylate group, and a second terminus comprising a target such as a protein or pharmaceutical agent or a reactive moiety capable of coupling to a target. Hydrogels can be prepared. The hydrogels can be used as a carrier for a protein or a pharmaceutical agent that can be readily released in a controlled fashion.
    Type: Application
    Filed: August 20, 2010
    Publication date: January 13, 2011
    Applicant: Nektar Therapeutics AL., Corporation
    Inventors: J. Milton Harris, Xuan Zhao
  • Publication number: 20110009594
    Abstract: The present disclosure provides copolymers of 2-substituted-2-oxazolines possessing two or three reactive functional groups which are also chemically orthogonal. The copolymers described may be random copolymers, block copolymers or a mixture of random and block copolymer configurations. Furthermore, the present disclosure provides novel methods for synthesizing the above polymers and for conjugating to molecules such as targeting, diagnostic and therapeutic agents.
    Type: Application
    Filed: January 12, 2009
    Publication date: January 13, 2011
    Applicant: SERINA THERAPEUTICS, INC.
    Inventors: Kunsang Yoon, J. Milton Harris, Michael David Bentley
  • Publication number: 20100330023
    Abstract: The present disclosure provides copolymers of 2-substituted-2-oxazolines possessing two or three reactive functional groups which are also chemically orthogonal. The copolymers described may be random copolymers, block copolymers or a mixture of random and block copolymer configurations. Furthermore, the present disclosure provides novel methods for synthesizing the above polymers and for conjugating to molecules such as targeting, diagnostic and therapeutic agents.
    Type: Application
    Filed: May 25, 2010
    Publication date: December 30, 2010
    Applicant: Serina Therapeutics, Inc.
    Inventors: Kunsang Yoon, Michael David Bentley, J. Milton Harris, Zhihao Fang, Tacey Viegas
  • Publication number: 20100298496
    Abstract: Multi-armed, monofunctional, and hydrolytically stable polymers are described having the structure wherein Z is a moiety that can be activated for attachment to biologically active molecules such as proteins and wherein P and Q represent linkage fragments that join polymer arms polya and polyb, respectively, to central carbon atom, C, by hydrolytically stable linkages in the absence of aromatic rings in the linkage fragments. R typically is hydrogen or methyl, but can be a linkage fragment that includes another polymer arm. A specific example is an mPEG disubstituted lysine having the structure where mPEGa and mPEGb have the structure CH3O—(CH2CH2O)nCH2CH2— wherein n may be the same or different for polya- and polyb- and can be from 1 to about 1,150 to provide molecular weights of from about 100 to 100,000.
    Type: Application
    Filed: August 3, 2010
    Publication date: November 25, 2010
    Applicant: Nektar Therapeutics
    Inventors: J. Milton Harris, Francesco Maria Veronese, Paolo Caliceti, Oddone Schiavon
  • Publication number: 20100286107
    Abstract: The invention provides corticosteroids that are chemically modified by covalent attachment of a water soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits a reduced biological membrane crossing rate as compared to the biological membrane crossing rate of the corticosteroid not attached to the water soluble oligomer.
    Type: Application
    Filed: October 3, 2008
    Publication date: November 11, 2010
    Applicant: Nektar Therapeutics
    Inventors: Wen Zhang, Jennifer Riggs-Sauthier, J. Milton Harris, Michael D. Bentley
  • Publication number: 20100267895
    Abstract: Conjugates between a protein and a water soluble polymer comprising multiple degradable carbonate linkages are provided.
    Type: Application
    Filed: June 29, 2010
    Publication date: October 21, 2010
    Applicant: Nektar Therapeutics
    Inventors: J. Milton Harris, Michael David Bentley, Xuan Zhao, Xiaoming Shen
  • Publication number: 20100249368
    Abstract: The present disclosure provides novel POZ-2 derivatives, methods for synthesizing POZ-2 derivatives and intermediates useful in such methods. In one embodiment, the POZ-2 derivative comprises two linear POZ chains of the present disclosure linked directly or indirectly to a branching moiety that contains a functional group for linking the POZ-2 derivative to the target molecule. Target molecule-POZ-2 conjugates are also described. In certain embodiment, the POZ-2 derivatives have low polydispersity values and a decreased amount of impurities produced by unwanted side reactions, such as, but not limited to, chain transfer.
    Type: Application
    Filed: September 29, 2008
    Publication date: September 30, 2010
    Applicant: SERINA THERAPEUTICS, INC.
    Inventors: J. Milton Harris, Michael David Bentley, Kunsang Yoon, Zhihao Fang
  • Patent number: 7786221
    Abstract: Multi-armed, monofunctional, and hydrolytically stable polymers are described having the structure wherein Z is a moiety that can be activated for attachment to biologically active molecules such as proteins and wherein P and Q represent linkage fragments that join polymer arms polya and polyb, respectively, to central carbon atom, C, by hydrolytically stable linkages in the absence of aromatic rings in the linkage fragments. R typically is hydrogen or methyl, but can be a linkage fragment that includes another polymer arm. A specific example is an mPEG disubstituted lysine having the structure where mPEGa and mPEGb have the structure CH3O—(CH2CH2O)nCH2CH2— wherein n may be the same or different for polya- and polyb- and can be from 1 to about 1,150 to provide molecular weights of from about 100 to 100,000.
    Type: Grant
    Filed: September 18, 2008
    Date of Patent: August 31, 2010
    Assignee: Nektar Therapeutics
    Inventors: J. Milton Harris, Francesco Maria Veronese, Paola Caliceti, Oddone Schiavon
  • Patent number: 7772357
    Abstract: A water soluble polymer comprising multiple degradable carbonate linkages in a backbone and, for each carbonate linkage in the backbone, an oligomer linked thereto by the carbonate linkage, wherein the oligomer is branched.
    Type: Grant
    Filed: September 14, 2009
    Date of Patent: August 10, 2010
    Assignee: Nektar Therapeutics
    Inventors: J. Milton Harris, Michael D. Bentley, Xuan Zhao, Xiaoming Shen
  • Publication number: 20100184937
    Abstract: An activated, substantially water-soluble polyoxazoline is provided having a linear or branched poly(ethylene glycol) backbone and at least one terminus linked to the backbone through a hydrolytically stable linkage, wherein the terminus is branched and has proximal reactive groups. The free reactive groups are capable of reacting with active moieties in a biologically active agent such as a protein or peptide thus forming conjugates between the activated polyoxazoline and the biologically active agent.
    Type: Application
    Filed: March 29, 2010
    Publication date: July 22, 2010
    Applicant: Nektar Therapeutics
    Inventors: J. Milton Harris, Antoni Kozlowski
  • Patent number: 7714088
    Abstract: An activated, substantially water-soluble poly(ethylene glycol) is provided having of a linear or branched poly(ethylene glycol) backbone and at least one terminus linked to the backbone through a hydrolytically stable linkage, wherein the terminus is branched and has proximal reactive groups. The free reactive groups are capable of reacting with active moieties in a biologically active agent such as a protein or peptide thus forming conjugates between the activated (polyethylene glycol) and the biologically active agent.
    Type: Grant
    Filed: March 24, 2009
    Date of Patent: May 11, 2010
    Assignee: Nektar Therapeutics
    Inventors: J. Milton Harris, Antoni Kozlowski
  • Publication number: 20100069579
    Abstract: The present disclosure provides terminally activated monofunctional POZ derivatives having a range of functional active groups allowing conjugation of the monofunctional POZ derivatives to a variety of target molecules under a wide range of reaction conditions to produce a hydrolytically stable target molecule-POZ conjugate. Furthermore, the present disclosure provides novel methods of synthesis for the disclosed terminally activated monofunctional POZ derivatives and hydrolytically stable target molecule-POZ conjugates created using the disclosed terminally activated monofunctional POZ derivatives.
    Type: Application
    Filed: February 28, 2008
    Publication date: March 18, 2010
    Inventors: J. Milton Harris, Michael David Bentley, Kunsang Yoon, Zhihao Fang, Francesco Maria Veronese
  • Publication number: 20100063328
    Abstract: This invention provides a method related to the preparation of derivatives of poly(ethylene glycol).
    Type: Application
    Filed: November 17, 2009
    Publication date: March 11, 2010
    Applicant: Nektar Therapeutics
    Inventors: Michael D. Bentley, J. Milton Harris, Antoni Kozlowski
  • Patent number: 7655747
    Abstract: PEG and related polymer derivatives having weak, hydrolytically unstable linkages near the reactive end of the polymer are provided for conjugation to drugs, including proteins, enzymes, small molecules, and others. These derivatives provide a sufficient circulation period for a drug-PEG conjugate, followed by hydrolytic breakdown of the conjugate and release of the bound molecule. In some cases, drugs that demonstrate reduced activity when permanently coupled to PEG maintain a therapeutically suitable activity when coupled to a degradable PEG in accordance with the invention. The PEG derivatives of the invention can be used to impart improved water solubility, increased size, a slower rate of kidney clearance, and reduced immunogenicity to a conjugate formed by attachment thereto. Controlled hydrolytic release of the bound molecule into an aqueous environment can then enhance the drug's delivery profile by providing a delivery system which employs such polymers and utilizes the teachings provided herein.
    Type: Grant
    Filed: February 4, 2005
    Date of Patent: February 2, 2010
    Assignee: Nektar Therapeutics
    Inventor: J. Milton Harris
  • Publication number: 20100004392
    Abstract: A water soluble polymer comprising multiple degradable carbonate linkages in a backbone and, for each carbonate linkage in the backbone, an oligomer linked thereto by the carbonate linkage, wherein the oligomer is branched.
    Type: Application
    Filed: September 14, 2009
    Publication date: January 7, 2010
    Applicant: Nektar Therapeutics
    Inventors: J. Milton Harris, Michael David Bentley, Xuan Zhao, Xiaoming Shen
  • Patent number: 7642323
    Abstract: This invention provides a method for preparing, in high purity and high yield, heterobifunctional derivatives of poly(ethylene glycol) or related polymers. A chromatographic purification step is not necessary in the method. In accordance with the method of the invention, an intermediate polymer having a formula of W-Poly-OH is provided bearing a removable group W at one terminus. The intermediate polymer W-Poly-OH is first altered by modifying the OH group to a first functional group X, followed by the removal of W to generate a second hydroxyl group. The latter hydroxyl group may then be further converted to a second functional group Y, thus providing the desired heterobifunctional derivative.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: January 5, 2010
    Assignee: Nektar Therapeutics
    Inventors: Michael D. Bentley, J. Milton Harris, Antoni Kozlowski
  • Patent number: 7608678
    Abstract: A water soluble polymer is described, the water soluble polymer comprising multiple hydrolytically degradable carbonate linkages in a backbone and, for each carbonate linkage in the backbone, an oligomer linked thereto by the carbonate linkage, wherein the oligomer is branched and, prior to being linked by the carbonate linkage, has the formula: R3[O—(—CHR1CH2—O—)n—]mH where R3 is a core branching moiety, R1 is H, (n) can range from 2 to 2000, and m is at least 3.
    Type: Grant
    Filed: August 3, 2007
    Date of Patent: October 27, 2009
    Assignee: Nektar Therapeutics
    Inventors: J. Milton Harris, Michael D. Bentley, Xuan Zhao, Xiaoming Shen